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Abstract
Rebound of HIV viremia after interruption of anti-retroviral therapy is due to the small population of CD4+ T cells that
remain latently infected. HIV-1 transcription is the main process controlling post-integration latency. Regulation of HIV-1
transcription takes place at both initiation and elongation levels. Pausing of RNA polymerase II at the 59 end of HIV-1
transcribed region (59HIV-TR), which is immediately downstream of the transcription start site, plays an important role in the
regulation of viral expression. The activation of HIV-1 transcription correlates with the rearrangement of a positioned
nucleosome located at this region. These two facts suggest that the 59HIV-TR contributes to inhibit basal transcription of
those HIV-1 proviruses that remain latently inactive. However, little is known about the cell elements mediating the
repressive role of the 59HIV-TR. We performed a genetic analysis of this phenomenon in Saccharomyces cerevisiae after
reconstructing a minimal HIV-1 transcriptional system in this yeast. Unexpectedly, we found that the critical role played by
the 59HIV-TR in maintaining low levels of basal transcription in yeast is mediated by FACT, Spt6, and Chd1, proteins so far
associated with chromatin assembly and disassembly during ongoing transcription. We confirmed that this group of factors
plays a role in HIV-1 postintegration latency in human cells by depleting the corresponding human orthologs with shRNAs,
both in HIV latently infected cell populations and in particular single-integration clones, including a latent clone with a
provirus integrated in a highly transcribed gene. Our results indicate that chromatin reassembly factors participate in the
establishment of the equilibrium between activation and repression of HIV-1 when it integrates into the human genome,
and they open the possibility of considering these factors as therapeutic targets of HIV-1 latency.
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Introduction
Following integration into the host cell genome, HIV-1
transcription is the most important step regulating viral replica-
tion. The main factor involved in this regulation is the viral Tat
protein, which binds TAR, a structured RNA element present at
the 59 end of the viral mRNAs. The structure of the mRNA 59 end
also contributes to the pausing of RNA polymerase II (RNApolII)
at the LTR [1]. This pausing is characteristic of HIV-1
transcription and appears to play a role in maintaining low levels
of basal transcription when the promoter is not activated [2,3].
Tat activates transcription by both inducing chromatin remod-
eling and recruiting P-TEFb, a cell factor required for productive
transcription elongation, onto the viral LTR [4,5]. Tat also
stimulates transcription by direct, TAR-independent activation of
the viral promoter [6]. Induction of the host transcription factors NF-
a B cooperates with Tat in completing HIV activation [7].
Chromatin plays an essential role in the transcriptional
regulation of HIV (reviewed by [8,9]). The transition from basal
to activated transcription correlates with drastic changes in the
acetylation levels of the nucleosomes covering the HIV promoter
[10] and with the rearrangement of nucleosome positioning on the
59 LTR [11]. These chromatin alterations are catalyzed by histone
modifying enzymes and ATP-dependent chromatin remodeling
complexes, which are recruited by Tat to the LTR [12–14]. Tat
action on HIV chromatin is also mediated by the nucleosome
assembly protein hNAP-1 [15].
Several host factors, including the receptor tyrosine kinase
RON [16] and a subunit of the CPSF complex [17], contribute
to maintaining the repressive state characteristic of HIV latency,
but most elements directly responsible for HIV postintegration
latency are also related to chromatin. Histone deacetylases
(HDAC) are involved in the transcriptional repression of the
LTR [18] and their recruitment by CBF-1 promotes HIV-1
entry into latency [19]. HP1, binding trimethylated histone H3-
K9, also plays a role in HIV-1 silencing [20]. Consistent with this
role of chromatin in HIV latency, the chromatin environment of
the integration site influences the transcriptional behavior of the
provirus, whose level of basal transcription is undetectable in
some integrants [21].
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One of the most interesting phenomena that takes place during
the transcriptional activation of a latent HIV-1 provirus is the
precise, transcription-independent remodelling of nucleosome-1,
positioned at the 59 end of HIV-1 transcribed region (59HIV-TR),
immediately downstream of the transcription start site [11]. In this
work, we performed a genetic analysis of the role of the 59HIV-TR
in basal transcription, making use of the yeast Saccharomyces
cerevisiae, which has already been successfully used to investigate
other aspects of HIV-1 biology [22–24]. We show that the 59HIV-
TR is critical in repressing basal transcription in yeast and that this
phenomenon is mediated by FACT, Spt6 and Chd1, proteins
involved in co-transcriptional chromatin reassembly. Finally, we
confirm that this group of factors plays a role in maintaining low
levels of basal transcription in human cells.
Results
The 59HIV-TR Inhibits Basal Transcription in Yeast
It has been previously described how the entire HIV-1 LTR is
transcriptionally inactive in yeast [25]. Therefore, in order to
investigate transcription elongation through the 59HIV-TR in
Saccharomyces cerevisiae, we constructed a chimeric yeast-HIV
transcription unit. We located a fragment of the HIV-1 transcribed
region (+1/+671), under the transcriptional control of a Ty1
promoter, which drives a retroelement with a low, but detectable,
level of basal transcription [26]. The fragment included all the
sequences that have been shown to be relevant in regulating HIV-1
transcriptional elongation. We did not choose a longer piece of HIV-
1 to avoid the complex pattern of spliced forms that characterize this
virus. In order to ensure its detection by northern blot, we increased
the length of the mRNA by adding the coding region of the yeast
PHO5 gene (Figure 1A). A transcript of the expected length (2.1 kb)
was detected when we transformed three different wild-type strains
of Saccharomyces cerevisiae with a centromeric plasmid containing the
Ty1-HIV construct (Figures 1A and Figure S1).
In order to explore whether the 59HIV-TR can influence
transcription in yeast, we deleted a 203 bp fragment of this region,
including most of the TAR-encoding R domain. The new
transcription unit, Ty1-HIVTARless, also expressed a transcript
of the expected length (1.9 kb). Quantification of the transcripts
revealed that the deletion produced a clear increase in the mRNA
amounts (Figures 1A and Figure S1). To confirm that this
difference was due to RNApolII pausing, we performed ChIP
experiments with a Myc-tagged form of Rpb1, the biggest subunit
of RNApolII. The results obtained with Ty1-HIV showed that the
amounts of RNApolII bound to the 59HIV-TR were higher than
the levels detected downstream (Figure 1B). This enrichment was
not due to the proximity to the initiation site, since we did not
detect a significant accumulation of RNApolII at the equivalent
region of Ty1-HIVTARless, immediately downstream of its
initiation site (Figure 1B).
One of the main factors regulating HIV-1 transcription is DSIF,
which exerts a negative influence on RNApolII transcription during
early elongation [27]. We analyzed the mRNA levels of Ty1-HIV
and Ty1-HIVTARless in an spt4D mutant lacking one of the
subunits of yeast DSIF. As expected, the absence of Spt4 partially
abolished the repressive role of the 59HIV-TR (Figure 1A).
In order to ascertain whether the TAR structure contributes to
the repressive role of the 59HIV-TR in yeast, we constructed a
mutant version of Ty1-HIV (Ty1-HIVTARmut), in which we
replaced the promoter-distal part of the TAR-encoding sequence
(59-GCTCTCTGGCTAACTAGGGAACCC-39) by a comple-
mentary string (59-CGAGAGACCGATTGATCCCTTGGG-39).
The new transcription unit, encoding an mRNA without the
ability to form a TAR structure, showed levels of expression
similar to Ty1-HIV and clearly below Ty1-HIVTARless
(Figure 1C), indicating that the phenomenon that we are
describing does not depend on the TAR element.
Non-active HIV-1 LTR is occupied by a set of positioned
nucleosomes, one of which covers the 59HIV-TR [11]. To complete
the characterization of Ty1-HIV, we digested chromatin and naked
DNA samples with micrococcal nuclease (MNase) and analyzed
nuclesome positioning by quantitative PCR. As shown in Figure 1D,
the transcribed region of Ty1-HIV showed a clearly defined
nucleosomal pattern, similar to HIV-1 in human cells. In contrast,
the pattern on the Ty1-HIVTARless transcribed region is
incompatible with a unique translational phase of nucleosomes,
suggesting a more dynamic chromatin structure with several
alternative distributions (Figure 1D). The higher accessibility of
Ty1-HIVTARless chromatin was also confirmed by hybridization of
MNase–treated samples with probes covering the 59end of its
transcribed region (Figure S2). Hybridization of Ty1-HIV samples
with probe 1, covering the 59HIV-TR produced a ladder of signals,
compatible with a regular nucleosomal structure, whose shortest
fragment was approximately 150 bp long. Similar results were
obtained with probe 3. In contrast, hybridization of Ty1-HIVTAR-
less samples with probe 2, covering the 59 end of its transcribed
region, produced a nucleosomal ladder that included a smeared
signal of DNA fragments shorter than 100 bp. Rehybridization with
probe 3, also showing a less regular nucleosomal ladder, excluded the
possibility that this smear was due to DNA degradation (Figure S2).
Taken together, the results shown so far indicate that Ty1-HIV is a
good tool for investigating transcription elongation through the
59HIV-TR, and suggest that the repressive role of this DNA element
in yeast is related to its chromatin structure.
It has been described how nucleotide deprivation stimulates Ty1
transcription [28]. We found that the addition of 6-azauracil, an
NTP-depleting drug, to the medium produced a rapid increase in
the overall level of Ty1 mRNA (Figure S3). We made use of this
simple method of activating the Ty1 promoter in order to study
the effect of promoter activation on 59HIV-TR transcription. We
observed that promoter activation eliminated the functional
differences between Ty1-HIV and Ty1-HIVTARless, which
became equally expressed in the presence of 6-azauracil. Similar
results were obtained in the absence of the RNApolII cleavage-
factor TFIIS (dst1D), suggesting that RNApolII does not become
arrested when transcribing the 59HIV-TR (Figure 2A).
Author Summary
Acquired immunodeficiency syndrome (AIDS) is caused by
the human immunodeficiency virus (HIV). Drugs used for
anti-viral therapy are very efficient in controlling the
presence of viral particles in infected patients. However, if
this therapy is interrupted, rebound of viremia occurs due
to the small population of cells that remain latently
infected. A specific region of the HIV genome (the
beginning of the transcribed region) plays an important
role in viral expression and may contribute to its silent
state in latently infected cells. We reconstructed a minimal
HIV system in yeast to perform a genetic analysis of the
role played by that specific region of the viral genome. We
found that the repressive role played by this region is
mediated by a group of proteins (chromatin reassembly
factors) so far associated with other functions during gene
expression. We confirmed that this group of factors plays a
role in controlling HIV-1 basal transcription in human cells.
Chromatin Reassembly in HIV-1 Transcription
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To further confirm that promoter activation abolishes the
repressive effect of the 59HIV-TR, we replaced the Ty1 promoter
by the one of GAL1, a tightly regulated gene that becomes strongly
activated when galactose is the carbon source. Under conditions of
weak activation (2% raffinose plus 0.02% galactose) a clear
difference was observed between GAL1-HIV and GAL1-HIV-
TARless (Figure 2B), indicating that the 59HIV-TR does not only
repress Ty1-driven transcription. As expected, when we added
high levels of galactose (2%) to the medium, we observed a further
increase in mRNA accumulation. However, in this case, the levels
of mRNA accumulation were the same in cells containing the
GAL1-HIV construct as in those transformed with GAL1-
HIVTARless (Figure 2C). This result shows again that the
repressive role of the 59HIV-TR is not effective under activating
conditions.
When HIV-1 promoter becomes active in human cells, the
TAR domain is required for full activation by Tat and P-TEFb.
We wondered whether the activation of the promoter in yeast still
allows a supplemental induction by Tat and P-TEFb. We
expressed hCDK9, hCycT1 and Tat by cloning their cDNAs in
yeast expression vectors (Figure S4A and B). We did not detect any
influence of Tat and P-TEFb on Ty1-HIV basal transcription
(Figure 2D). We were also interested in testing the effect of Tat and
P-TEFb on Ty1-HIV expression under activating conditions. The
Figure 1. Influence of the 59 end of HIV-1 transcribed region on basal transcription in yeast. (A) The 59HIV-TR inhibits Ty1-HIV-1
expression and this inhibition partially depends on yDSIF. mRNA samples from the BY4741 wild-type yeast strains and from an isogenic spt4D strain,
transformed with plasmids pTy1-HIV and pTy1-HIVTARless, were resolved in agarose gels and analyzed by Northern blotting. Quantification of the
signals is shown, after normalizing with the levels of 25S rRNA. A typical result and the quantification of three independent experiments are shown.
(B) ChIP analysis of RNApol II in the two indicated transcription units. ARG3 cells, isogenic to BY4741, except for the RPB1::cMyc allele, transformed
with pTy1-HIV and pTy1-HIVTARless, were grown to mid-log phase. Cross-linked chromatin was immunoprecipitated with monoclonal anti-Myc
antibody. PCR was conducted on two dilutions of whole cell extract (WCE) and two different amounts of immunoprecipitated DNA (IP; only the most
diluted are shown). PCR primers flank segments located in the 59, central and 39 regions of each gene. Diagrams at the top indicate the position of
the PCR amplicons relative to the HIV-1 transcription start site. A non-transcribed region adjacent to FUS1 was used as a control. A typical experiment
for each gene is shown on the left and the averages of three independent experiments are quantified on the right. The HIV signals are marked with
an asterisk. (C) The TAR RNA structure is not required for the repressive effect of the 59HIV-TR on basal transcription. Northern analyses of Ty1-HIV,
Ty1-HIVTARless and Ty1HIVTARmut in BY4741 were performed as in A. (D) Chromatin configuration of the 59HIV-TR in yeast. Spheroplasts of
formaldehyde-treated BY4741 cells containing pTy1-HIV and pTy1-HIVTARless were lysed and digested with MNase. After purification, DNA was
quantified with real-time PCR as described in Materials and Methods, using the primers listed in Table S3. Signals were normalized against naked DNA
by repeating the same procedure with control DNA, purified from formaldehyde-treated cells before digesting it with MNase. For comparison, the
two profiles were represented as fractions of the signal obtained with amplicon 14 (+490/+537). Diagrams represent the estimated locations of
positioned nucleosomes. Dashed ovals indicate possible alternative locations of nucleosomes in TyHIVTARless.
doi:10.1371/journal.pgen.1000339.g001
Chromatin Reassembly in HIV-1 Transcription
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addition of 6AU to these cells produced very irregular results,
likely due the presence of three different plasmids in this strain and
to the plasmid instability produced by 6-azauracil [29]. As an
alternative approach, we tested the effect of Tat and P-TEFb on a
more active Ty1-HIV by repeating the assay in an spt4D strain. In
this case we obtained consistent results and a weak but significant
effect was detected (Figure 2D). We also detected a positive effect
of P-TEFb on activated GAL1-HIV expression, which was strictly
dependent on CycT1 and partially dependent on CDK9 (Figure
S4C). We analyzed whether this second level of activation was
mediated by the 59HIV-TR, encoding the TAR RNA domain. As
expected, Tat and P-TEFb were unable to enhance the expression
of GAL1-HIVTARless (Figure 2C). This set of results suggests that
the repressive role of the 59HIV-TR and the TAR-dependent
regulation of HIV-1 transcription can be functionally separated.
Genetic Analysis of the 59HIV-TR Repressive Function
We then analyzed the expression of Ty1-HIV and Ty1-
HIVTARless in a selected group of mutants related to the
elongation step of transcription. The results of these analyses are
shown in Figure S5 and 3A. Some of the mutants tested, such as
swi2D, lacking a subunit of the SWI-SNF chromatin remodeling
complex, set1D, affecting the COMPASS histone-methylation
complex, or rpd3D, lacking one of the main histone deacetylases,
did not produce a significant effect on the expression of any of the
two chimeric transcription units. We concluded that these factors
do not contribute significantly to either elongation through the
59HIV-TR or Ty1 promoter activity.
Some other mutants, such as paf1D, lacking the main subunit of
the PAF1 complex; spt2-150, affected in a HMG component of
yeast chromatin; those affecting the SAGA complex (gcn5D, spt3D,
spt8D), or those lacking elements of cyclin-dependent kinases
involved in transcription (bur2D, ctk1D) produced a negative effect
on the expression of both Ty1-HIV and Ty1-HIVTARless (Figure
S5). The simplest interpretation of these results is that this set of
factors is required for the basal activity of the Ty1 promoter and/
or for transcription elongation through both Ty1-HIV and Ty1-
HIVTARless. In any case, it seems that these factors are not
related to the repressive effect of the 59HIV-TR.
The absence of Isw1, the catalytic subunit of the ISW1
chromatin remodeling complexes, stimulated the expression of
both Ty1-HIV and Ty1-HIVTARless (Figure S5). This result is
fully consistent with the described role of Isw1 in inhibiting Ty1
expression [30]. A similar result was obtained with the ioc2D
mutant, lacking one of the subunits of the ISW1b complex.
However, the absence of Ioc3 or Ioc4, belonging to the ISW1a
and ISW1b complexes respectively, enhanced the expression of
Ty1-HIV but decreased that of Ty1-HIVTARless (Figure S5).
These results confirm the intricacy of the roles played by the ISWI
complexes [31] and might suggest their involvement in the
Figure 2. No effect of the 59HIV-TR on mRNA levels upon promoter activation. (A) Activation of the Ty1 promoter by the NTP-depleting
agent 6-azauracil eliminates the inhibitory effect of the 59HIV-TR, both in a wild type and in a strain lacking TFIIS (dst1D). Experiment details as for
Figure 1A. (B) The 59HIV-TR inhibits GAL1-driven transcription when the promoter is weakly active. Cells transformed with plasmids pGAL1-HIV or
pGAL1-HIVTARless were grown to mid-log phase in minimal medium with raffinose (0%) or with raffinose plus 0.02% galactose (0.02%) as carbon
sources. (C) No effect of the 59HIV-TR on mRNA levels is detected when an activated GAL1 promoter drives transcription, unless Tat and P-TEFb are
present in the yeast cell. Cells transformed with plasmids pGAL1-HIV or pGAL1-HIVTARless, alone or together with p415GPD-CycT1, p414GPD-Cdk9
and p413GPD-Tat, were grown to mid-log phase as in B and incubated for 90 min in the presence of 2% galactose. (D) Tat and P-TEFb enhance Ty1-
HIV expression in spt4D but they do not alter basal transcription in the wild type. Cells transformed with plasmids pTy1-HIV or pTy1-HIVTARless, alone
or together with p415GPD-CycT1, p414GPD-Cdk9 and p413GPD-Tat, were grown to mid-log phase. In all cases, mRNA samples were taken and
analyzed by Northern blot as in Figure 1A and the averages of three independent experiments are shown.
doi:10.1371/journal.pgen.1000339.g002
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repressive effects of the 59HIV-TR, but are difficult to interpret
properly without further research.
A last group of mutants included chd1D, lacking a chromodo-
main protein involved in transcription elongation; spt16-197,
affecting one of the subunits of the FACT elongation factor; and
spt6-140, encoding a defective form of a factor related to
chromatin and mRNA transactions during elongation [32–34].
Both SPT16 and SPT6 are essential genes and, like CHD1, are
involved in the reassembly of chromatin during transcription
elongation [35]. Strong functional interactions have been detected
amongst these three genes [36–38]. This group of mutants did not
significantly affect the expression of Ty1-HIVTARless but did
increase the levels of Ty1-HIV mRNA, a phenotype very similar
to that of spt4D (Figure 3A, 3B and S5).
Spt16, FACT and Chd1 are general chromatin factors that are
associated with actively transcribed regions in all eukaryotes
Figure 3. Genetic analysis of the 59HIV-TR inhibitory effect. (A) The inhibitory role of the 59HIV-TR is compromised in mutants affecting co-
transcriptional chromatin reassembly. mRNA samples of the indicated mutants, transformed with pTy1-HIV and pTy1-HIVTARless, were analyzed by
Northern blot, as in Figure 1A. Averages of three independent experiments (see Figure S5) were plotted. Dashed line represents all possible variations
of mRNA levels that maintain the Ty1HIV/Ty1HIVTARless proportion of the wild type. The grey square covers all points with a level of Ty1HIV mRNA
significantly higher than the wild type (more than two standard deviations), but with a similar level of Ty1HIVTARless mRNA that the wild type (within
two standard deviations). (B) Representative Northern blots, comparing the mRNA levels of Ty1-HIV and Ty1-HIVTARless, in spt6-140 (FY137), spt16-
197 (FY348), chd1D and their respective isogenic wild-type strains (FY120 and BY4741). (C) ChIP analysis of Spt6, Spt16 and Chd1. SJY25, DBY871 and
DBY969 strains, transformed with pTy1-HIV, were grown to mid-log phase. Cross-linked chromatin was immunoprecipitated and quantified by real-
time PCR as described in Materials and Methods. Averaged fold enrichments of three independent experiments, relative to an untranscribed
telomeric region, are shown. (D) Chromatin configuration of the 59HIV-TR in spt4D, spt6-140 and chd1D. Averages of three independent experiments
are shown. Experimental details as in Figure 1D.
doi:10.1371/journal.pgen.1000339.g003
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investigated so far [39–41]. Since they seemed to play a role in the
weakly transcribed Ty1-HIV, we tested the presence of these
factors on this transcription unit by ChIP. We found significant
enrichments for the three proteins on Ty1-HIV (Figure 3C). In all
three cases, the enrichment was higher on the transcribed region
than on the promoter, confirming the well-known connection of
these factors with transcription elongation.
These results suggest that the repressive function of the 59HIV-
TR depends on chromatin reassembly. To further corroborate this
hypothesis, we analyzed the expression of Ty1-HIV and Ty1-
HIVTARless in hta1D-htb1D, a mutant suffering from a deficit of
H2A and H2B histones. The expression of Ty1-HIVTARless was
not significantly affected in this mutant, whereas the mRNA levels
of Ty1-HIV showed a clear increase (Figure 5S). Thus, hta1D-
htb1D grouped with spt4D and the three chromatin-reassembly
mutants (Figure 3A).
In order to verify that this group of mutants was indeed affecting
the chromatin structure of Ty1-HIV, we analyzed nucleosome
positioning on Ty1-HIV in some of the mutants (Figure 3D). spt4D
caused a general alteration of nucleosome positioning on the
transcribed region of Ty1-HIV, clearly affecting nucleosomes 1, 2
and 3. In the overlapping region, this pattern was very similar to
the one exhibited by Ty1-HIVTARless in the wild type
(Figure 1D). spt6-140 also showed a less positioned pattern than
the wild type, although in this case nucleosome 2 was almost
unaffected. In turn, chd1D almost eliminated the signal corre-
sponding to nucleosome 2 without significantly affecting the other
two nucleosomes (Figure 3D).
Chromatin Reassembly Factors Contribute to Repressing
HIV-1 Basal Transcription in Human Cells
In order to investigate whether chromatin reassembly factors
really do play a role in the repression of HIV-1 basal transcription
in human cells, we knocked down the expression of human Spt6
and Chd1 in HIV latently infected cells. A model of HIV-1 latency
in Jurkat cells infected with an HIV minigenome encoding Tat
and GFP has been previously reported [42]. Upon infection, latent
cells are defined as those that do not express constitutively GFP,
but need further stimuli of HIV promoter by mitogens (PMA) or
cytokines (TNF-a). After removal of stimuli, the HIV promoter
becomes repressed again and GFP-negative cells can be purified
and maintained as a population; alternatively, individual cells
representing unique latent viral integrations can be cloned. These
cells are useful for investigating maintenance of HIV promoter
repression and viral latency. We hypothesized that, if chromatin
reassembly factors were involved in HIV promoter repression, its
depletion would cause gene reactivation.
We used lentiviral shRNA expression vectors to deplete Spt6
and Chd1 in HIV latently infected cell populations (Figure 4A).
10–15 days after shRNA infection and puromycin selection, the
percentage of Spt6 and Chd1 knocked-down cells expressing GFP
reached ca. 5%, a significantly higher proportion that obtained
with a control shRNA vector (Figure 4B). Because the latently-
infected cell population is heterogeneous, representing a myriad of
HIV integrations at different genome locations and chromatin
environments, only a small proportion of latent HIV provirus are
activated by solely depleting these factors. A similar degree of
reactivation was obtained with an shRNA against YY1, a host
transcription factor previously reported to be involved in histone
deacetylase (HDAC) recruitment and HIV promoter repression
[43,44] (Figure 4B). The HDAC inhibitor trichostatin A (TSA)
activates the HIV promoter in ca. 9.5% of the latently-infected cell
population, indicating again that not all HIV integrations are
equally sensitive to the inhibition or depletion of a repressive
chromatin factor (data not shown).
Next, we investigated the effect of Spt6 and Chd1 depletion on
HIV expression in particular clones containing single latent
integrations either in centromeric alphoid repeats (clones H2 and
C1), an intergenic region (clone A1) or in an intron of the highly
transcribed gene UBXD8 (clone 27) [42] (and unpublished results).
The percentage of reactivated cells varied depending upon the
clones, reaching ca. 30% reactivation in clone 27 after knocking-
down Spt6 (Figure 4C and 4D). Reactivation by TSA is also
dissimilar between clones, ranging from 27% in clone C1 to 47%
in clone 27 (Figure 4C and data not shown). Similarly, Spt6 and
Chd1 depletion promoted reactivation of the silent HIV promoter
in a newly-generated model of HIV latency in HeLa cells (Figure
S6). Moreover, these effects were observed with several different
shRNA sequences and correlated well with the degree of target
protein depletion achieved, discarding unspecific off-target effects
(Figure S6). Altogether, our data indicates that these two
chromatin reassembly factors identified in the yeast screening
contribute to maintain HIV repression in infected human cells.
Discussion
In this work we have made use of yeast genetic analysis to
investigate the influence of the 59HIV-TR on basal transcription.
Several attempts to study HIV-1 transcription in yeast have been
described, all of them focused in the transactivation capacity of
Tat. Although a fusion of Tat with the DNA binding domain of
Gal4 can activate the GAL1 promoter [45], no Tat-dependent
transactivation of the HIV-1 LTR had yet been achieved [25].
Therefore, the present work is the first successful reconstruction in
yeast of a transcriptional system based on HIV-1 elements.
The artificial character of the Ty1-HIV transcription unit raises
the possibility of the conclusions extracted from this work being of no
relevance for HIV-1 biology. Several results presented in this piece of
research argue against that point of view. We show that the 59HIV-
TR not only represses transcription driven by the Ty1 promoter but
can also act on a completely different promoter (GAL1) when this is
weakly active. We also show that the 59HIV-TR induces an
accumulation of RNApol II immediately downstream of the
promoter, a very common situation throughout the human genome
but extremely infrequent in yeast [46]. It has been recently proposed
that the reason for this difference is the chromatin organization of the
transcription start site, which is usually covered by a positioned
nucleosome in yeast and immediately upstream of a positioned
nucleosome in most metazoan genes [47]. We show in this work that
the chromatin organization of the HIV fragment present in Ty1-
HIV closely resembles the distribution of positioned nucleosomes of
HIV-1 proviruses in the human genome. We also present evidence
that transcription through the 59HIV-TR in yeast is influenced by
factors that have been previously shown to govern HIV-1
transcription elongation: yDSIF contributes to the repressive role
of the 59HIV-TR in basal transcription, whereas Tat and P-TEFb
enhance active transcription in a 59HIV-TR-dependent manner.
Finally, the main conclusion of the genetic analysis, which is the
involvement of chromatin reassembly factors in repressing HIV-1
basal transcription, has been confirmed in a human model of HIV-1
latency. Based on these considerations, we believe that the chimeric
yeast-HIV system is a valid complementary tool for HIV research.
The role of the 59HIV-TR in basal transcription has scarcely
been studied, and the data available is sometimes contradictory
[48,49], likely due to the use of transiently transfected DNA, which
does not ensure a proper organization of DNA in chromatin [50].
In fact, mutation in this region produced different effects on HIV-
Chromatin Reassembly in HIV-1 Transcription
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1 transcription when an integrated version was compared to a
transiently transfected one [51,52].
The data shown in the present work indicates that the 59HIV-
TR contributes to maintaining low levels of basal transcription
without interfering with promoter activation. The genetic analysis
that we have performed shows a contribution of chromatin
reassembly factors to this repressive function of the 59HIV-TR.
We have also confirmed that Spt6 and Chd1 favor a close
chromatin configuration on the transcribed region of Ty1-HIV.
The role of chromatin reassembly factors at this level seems to be
as significant as the one played by DSIF, since the combination of
the chromatin alterations produced by spt6-140 and chd1D fully
matches those caused by spt4D. Deletion of the 59HIV-TR causes
a disruption of nucleosome positioning on the rest of the HIV
fragment present in Ty1-HIVTARless, mimicking the patterns of
spt4D and, to a lesser extent, of spt6-140. It is possible that this
chromatin difference between the two transcription units is a
consequence of the higher transcription level of Ty1-HIVTARless.
Alternatively, the absence of the +1 nucleosome may destabilize
the overall chromatin configuration and this would, in turn, give
rise to increased transcriptional activity. The differences in the
chromatin patterns of spt4D, spt6-140 and chd1D, all showing
similar levels of expression, indicate that the chromatin differences
are likely to be responsible for the transcription increase and not
vice versa. This explanation also fits better with the accumulation
of RNApolII on the 59HIV-TR and with the results of our genetic
analysis. In this scenario, productive elongation would be
infrequent under non-activating conditions due to both the low
number of initiation events and the positioned nucleosomes sitting
on the 59HIV-TR but, in those rare occasions when RNApol II
gets through the chromatin boundary, the immediate action of
chromatin reassembly factors (recruited by elongating RNApolII
itself) would contribute to rebuilding the repressive chromatin
configuration, avoiding a transition into an activation-prone
chromatin environment (Figure 5A).
Several chromatin-mediated mechanisms contribute to regulat-
ing HIV-1 transcription [8]: the activation of the LTR promoter is
mediated by the acetylation state of its chromatin, especially by the
nucleosome located upstream in the LTR (nucleosome 0) [10]. An
additional role of chromatin in regulating HIV-1 transcription
takes place at the level of early elongation, since the positioned
nucleosome covering the 59HIV-TR (nucleosome 1) becomes
remodeled in response to promoter activation, in a transcription-
independent manner [11].
Figure 4. shRNA-mediated depletion of chromatin reassembly factors hSpt6 and hChd1 in Jurkat cells derepress latently-
integrated HIV. (A) shRNA-mediated depletion of SPT6 and CHD1. A population of HIV (LTR-Tat-IRES-GFP-LTR) latently-infected human cells was
infected with Control, Spt6 (#1, target sequence CGCCTTGTACTGTGAATTTAT) or Chd1 (#3, GCAGTTGTGATGAAACAGAAT) shRNA expression
lentiviruses (pLKO.1-Puro) and, 10 days after puromycin (2 mg/ml) selection, depletion of these factors was tested in Western blot with specific
antibodies and tubulin as a loading control. (B) HIV reactivation in a heterogeneous population of HIV latently infected Jurkat cells, expressed as
percentage of cells that become GFP-positive 10–15 days after infection with the indicated shRNA-expressing lentiviruses and continuous selection
with puromycin. Values represent the mean6SD of three independent infection experiments. (C) Example of FACS analysis of GFP expression as a
result of HIV promoter reactivation in a latently infected Jurkat clone after infection with a Spt6 specific shRNA-expressing vector or treatment with
PMA (10 nM for 16 h) or TSA (400 nM for 16 h). The percentage of GFP-positive cells is indicated inside the corresponding gate. (D) HIV reactivation
in individual cell clones. Four different clones containing single HIV latent integrations previously mapped were infected with the indicated shRNA-
expressing lentiviruses, selected by puromycin treatment, and GFP expression was monitored by FACS over time. Values represent the mean6SD of
percentage of GFP-positive cells of two independent experiments 10–15 days after infection.
doi:10.1371/journal.pgen.1000339.g004
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Although transcription of Ty1-HIV is more intensively repressed
by chromatin reassembly factors than Ty1-HIVTARless, we do not
believe that the 59HIV-TR is specifically required for their
recruitment. Spt6, FACT and Chd1 are general elongation factors,
whose association to actively transcribed regions, in an RNA
polymerase II-dependent manner, is well documented from yeast
to metazoa [33,38–41,53–55]. We favour the idea of the 59HIV-
TR being an optimal DNA sequence for nucleosome positioning.
Recent genome-wide studies show the importance of 59 sequences
in specifying the location of +1 nucleosomes. In turn, these act as
barriers against which other nucleosomes are packed [56]. In such
a DNA context the repressive action of chromatin reassembly
factors would be maximal.
Basal transcription of HIV-1 is highly dependent on the
chromatin environment of integration sites [21]. Nevertheless,
mutations affecting the sequences located at the 39 border of
nucleosome 1, which increase its stability, produce a general
reduction in basal transcription, irrespective of the integration site
[57]. In contrast, the deletion of 60 nucleotides within the
sequence covered by this nucleosome, which presumably destabi-
lize it, makes basal transcription even more dependent on the
integration site than the wild type [57]. This data is fully
compatible with our yeast results and provides support for
chromatin configuration playing a role in repressing HIV-1
transcription at the level of early elongation. A similar mechanism
has been reported for the human hsp70 gene [58], where the
repressive chromatin configuration covering its transcribed region
becomes remodeled during activation, allowing poised RNApolII
to complete elongation [59].
The most relevant conclusion of our genetic analysis is the
involvement of chromatin-reassembly factors in repressing HIV-1
basal transcription. We have confirmed that their function is not
restricted to our chimeric yeast-HIV system but they are also
playing a role in HIV-1 basal transcription in human cells. It has
been reported that integration into regions of compacted
chromatin, i.e. centromeric heterochromatin, causes HIV pro-
moter inactivity, probably due to the inaccessibility of the basal
transcriptional machinery or the inability of transcription factors
to overcome the repressive chromatin state imposed [42]. In the
latent integrations, this repressive state can be overcome by
exogenous stimulation with mitogens or cytokines. We have found
that, by knocking-down Spt6 and Chd1, the HIV promoter
integrated in the context of latency increases its level of expression.
When we deplete Spt6 or Chd1 from the heterogeneous
population of HIV latently infected cells, only a small proportion
of integrant promoters are activated. This indicates that only a
subset of integrations are either negatively regulated by these
factors, or able to be reactivated by solely depleting them. In some
chromatin environments, transcription may be completely inhib-
ited, such that chromatin disruption by basal transcription would
not be an issue and chromatin reassembly factors would play no
role. Similarly, TSA treatment and YY1 depletion are not able to
reactivate all latent integrations. We had predicted that individual
integrations would have a more consistent response to the
depletion of reassembly factors. In fact, we observed that
individual clones responded differently, both amongst themselves
and to the two distinct shRNAs. Still, not all cells of a clonal
population respond equally. This behavior is also observed in
response to TSA and resembles position effect variegation [42].
Depletion of Spt6 and Chd1 may cause a deficit of chromatin
reassembly in those rare events, during non-activated conditions,
in which RNApolII would be able to overcome the chromatin
barrier (Figure 5A). This chromatin change would facilitate
additional rounds of transcription under non-activating conditions
Figure 5. A model for the contribution of chromatin reassembly factors to the repression of HIV basal transcription. (A) Chromatin
reassembly factors, recruited by the elongating form of RNApol II, stabilize nucleosomes on the transcribed region, keeping basal transcription at low
rates. In the absence of chromatin reassembly factors, nucleosomal configuration of the transcribe region becomes instable, increasing basal
transcription and eventually favoring promoter activation. (B) Chromatin reassembly factors may also contribute to the silencing of HIV by
transcriptional interference. HIV proviruses integrated in highly expressed genes would remain untranscribed due to the repressive chromatin
configuration established by chromatin reassembly factors during transcription elongation. In the absence of chromatin reassembly factors,
nucleosomes repressing the 59-LTR become instable, allowing transcription factors to activate the HIV promoter.
doi:10.1371/journal.pgen.1000339.g005
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and, eventually, an increase in transcription factor loading and
PIC assembly. If transcription were enough to produce some Tat
protein, then promoter activity would be reinforced. Inhibition of
HDAC activity with TSA has a similar effect, supporting the idea
that discrete modifications of chromatin compactness may be
sufficient to switch a repressed provirus to active.
It has been shown absence of chromatin reassembly factors in
yeast provokes activation of cryptic promoters located in the body of
transcribed genes. In the absence of transcription, no PIC assembles
on these cryptic promoters, due to the inhibitory action of
chromatin; under active transcription, chromatin reassembly factors
ensure rapid nucleosome deposition after RNApol II passage,
avoiding the activation of cryptic promoters [54,60]. HIV proviruses
integrated in highly transcribed genes are usually latent [61]. Several
mechanisms of transcriptional interference have been proposed to
explain this phenomenon [62]. It has been shown that read-through
transcription from an upstream promoter can interfere with HIV
transcription by disturbing PIC assembly [63]. Recent published
evidence indicates that transcriptional interference is caused by the
elongating form of RNA pol II, transcribing through the latent HIV
copy [64,65]. This situation parallels that of yeast cryptic promoter
and, accordingly, it is likely that chromatin reassembly factors also
play an important role inmaintaining HIV latency by transcriptional
interference (Figure 5B). The integration site of one of the individual
clones tested in our depletion experiments (clon 27) is a highly
transcribed gene. We found a clear reactivation of the latent HIV
copy of this clone when chromatin reassembly factors were depleted.
In fact, when Spt6 was depleted, this clone showed the maximal
reactivation level reached in the whole set of experiments.
When taken together, our results indicate that Spt6 and Chd1
participate in the mechanism that controls the equilibrium between
activation and repression of HIV-1 expression when the provirus is
integrated in the human genome, which depends greatly on the
chromatin environment of the integration site. Disturbance of this
equilibrium, by depleting chromatin reassembly factors for example,
makes some of the latent integrations become activated. These
factors may also play a general role in repressing basal transcription
throughout the human genome. Therefore, the specificity of
chromatin reassembly factors in repressing viral basal transcription
should be carefully evaluated before considering them as therapeutic
targets against HIV-1 latency.
Materials and Methods
Yeast Strains, Plasmids, and Media
Yeast strains used are listed in Table S1 and are isogenic to the
S288C derivative BY4741 [66]. Plasmids are described in Table
S2. Yeast cells were grown following standard procedures [67].
Measurement of mRNA Levels
mRNA levels were measured by Northern analysis as described
[29].
Western Blots
Laemmli boiled crude extracts were run on a 10% SDS-
polyacrylamide gel and transferred to nylon membranes (Hybond-
ECL). After blocking with Tris-buffered saline containing 0.1%
Tween 20 and 5% milk, proteins were detected using anti-FLAG
antibodies (monoclonal, Santa Cruz) and human cyclin T1
(polyclonal, Santa Cruz) and peroxidase-conjugated goat anti-mouse
and rabbit anti-goat IgG respectively. Blots were washed with tris-
buffered saline and 0.1% Tween 20, and developed by enhanced
chemiluminescence reactions (PIERCE). Signals were detected with
Hyperfilms ECL (Amersham), exposing from 15 sec to 5 min.
Chromatin Immunoprecipitation Assays
ChIP analyses of Rpb1-Myc were performed using a monoclonal
anti-cMyc antibody (9E10) as described previously [55]. For
crosslinking, cells were treated with 1% formaldehyde for 15 min
at room temperature. As a non-transcribed control, we amplified a
region adjacent to FUS1. Primer mixes were empirically adjusted for
balanced signals. Immunoprecipitation was defined as the ratio of
each gene-specific product in relation to that of the non-transcribed
region, always after normalization with the signal of its correspond-
ing whole-cell extract. Several dilutions of the whole cell extract were
tested to ensure that the assays were in the linear range.
Spt16-Myc, Spt6-HA and Chd1-HA abundances on Ty1-HIV
were assayed as indicated, by using ChIP with monoclonal anti-
cMyc (9E10) or anti-HA antibodies and protein A-Sepharose. We
used 20- to 30-bp oligonucleotides for PCR amplification of
fragments of the Ty1 promoter (positions 2157 to 2107, relative
to the transcription start site) and the 59HIV-TR (positions +102 to
+162). Real-time quantitative PCRwas performed with SYBR green
dye in the 7500 Real Time PCR system of Applied Biosystems by
following the manufacturer’s instructions. A non-transcribed
telomeric fragment was used to normalize the signals. No-antibody
controls were performed to exclude unspecific amplification.
Chromatin Analysis
Yeast spheroplasts and micrococcal nuclease digestions were
performed according to [68] with the modifications of [69].
Spheroplasts were prepared from mid-log phase cultures grown in
SC-Ura with 2% glucose. Cells were lysed and immediately
digested with 7.5 to 125 mU of micrococcal nuclease. Digested
DNA was resolved in 1.5% agarose gels and analyzed by Southern
blot with the probes indicated in Figure S2. Alternatively, DNA
was quantified by real time PCR performed with SYBR green dye
in a Applied Biosystems 7500 Real Time PCR system, following
the manufacturer’s instructions. In order to correct for the
sequence-specificity of MNase, naked-DNA samples digested with
MNase were also quantified by real-time PCR. The chromatin/
naked-DNA ratio was considered to be a valid estimation of
chromatin-dependent resistance to MNase.
shRNA-Mediated Depletion of hSpt6 and hChd1 and HIV
Expression Analysis
Pools or particular clones of Jurkat cells latently infected with an
HIV-derived minigenome [42] were infected with Control, YY1,
Spt6 or Chd1 shRNA-expressing lentiviruses (vector pLKO.1-
Puro) obtained from Sigma (MISSIONTM shRNAs). The protocol
for viral particles production and cell infections has been described
elsewhere [42]. Upon puromycin (2 mg/ml) selection of infected
cells, HIV reactivation was followed by FACS analysis of GFP-
positive cells. shRNA-mediated inhibition was tested by Western
blot with specific anti-human YY1 antibodies (Santa Cruz sc-281),
Spt6 (Abcam ab32820) and Chd1 (Abnova H00001105-A01).
Anti-tubulin antibody was from Sigma.
A pool of latently infected HeLa cells was constructed as
previously reported [42] and infected with several Spt6 and Chd1
shRNA-expressing vectors. Further details are described in the
legend of the Figure S6.
Supporting Information
Figure S1 Inhibitory effect of the 59HIV-TR on basal transcrip-
tion in three different yeast genetic backgrounds. mRNA samples
from three different wild-type yeast strains, transformed with
plasmids pTy1-HIV and pTy1-HIVTARless, were resolved in
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agarose gels and analyzed by Northern blotting. Quantification of
the signals is shown, after normalizing with the levels of 25S rRNA.
Found at: doi:10.1371/journal.pgen.1000339.s001 (2.90 MB TIF)
Figure S2 The 59HIV-TR is protected against MNase digestion
in yeast. Spheroplasts of BY4741 cells containing pTy1-HIV and
pTy1-HIVTARless were lysed and digested with increasing
concentrations of MNase. After purification, DNA was resolved
in agarose gels and hybridized with probes corresponding to the
positions indicated in the diagram. The arrow points to the
detected DNA fragments of subnucleosomal size.
Found at: doi:10.1371/journal.pgen.1000339.s002 (3.51 MB TIF)
Figure S3 Induction of Ty1 expression by 6-azauracil. Yeast cells
of BY4741 and an isogenic strain lacking TFIIS (dst1D), transformed
with the URA3-containing plasmid pRS416, were grown to mid-log
phase in minimal medium without uracil. Samples were taken at the
indicated times, after adding 6-azauracil (100 mg/ml). mRNA was
extracted and analyzed by Northern blot with a Ty1 probe. Signals
were normalized in accordance with the amounts of 25S rRNA.
Averages of three independent experiments are shown.
Found at: doi:10.1371/journal.pgen.1000339.s003 (2.31 MB TIF)
Figure S4 Effect of P-TEFb on GAl1-HIV expression in the
presence of Tat. (A) Expression of human cyclin T1 and human
FLAG-CDK9 in yeast was verified by Western blot with anti-
hCycT1 an anti-FLAG antibodies. (B) Expression of functional Tat
in yeast was verified following a triple-hybrid strategy, according to
Fraldi et al (J Cell Biochem 36: 247–253). Expression of lacZ was
detected when Tat was expressed in the MVcoat-b yeast strain. (C)
W303-1A cells transformed with plasmids pGAL1-HIV, alone or
together with combinations of p415GPD-CycT1, p414GPD-Cdk9
and p413GPD-Tat, were grown to mid-log phase in minimal
medium with glycerol and lactate as carbon sources, and incubated
for 90 min in the presence of 2% galactose. mRNA samples were
taken at different times and analyzed by Northern blot with an HIV
probe. Signals were normalized in accordance with the amounts of
25S rRNA. Averages of four independent experiments are shown.
Found at: doi:10.1371/journal.pgen.1000339.s004 (14.57MBTIF)
Figure S5 The inhibitory role of the 59HIV-TR is compromised in
mutants affecting co-transcriptional chromatin reassembly. mRNA
samples of the indicated mutants, transformed with pTy1-HIV and
pTy1-HIVTARless, were analyzed by Northern blot, as in Figure 1A.
Averages of at least three different experiments are shown.
Found at: doi:10.1371/journal.pgen.1000339.s005 (3.28 MB TIF)
Figure S6 shRNA-mediated depletion of chromatin reassembly
factors hSpt6 and hChd1 in a HeLa model of viral latency
derepress the integrated HIV promoter. (A) Inducible HIV
promoter in HeLa cells. HeLa cells were infected with a HIV
minigenome, LTR-Tat-IRES-GFP-LTR. GFP-positive and GFP-
negative cells were purified by cell sorting. Thereafter, GFP-
negative cells were treated with TNFa overnight and resulting
GFP-positive cells were purified to establish a population of
latently infected cells. After several weeks in culture in the absence
of TNFa, the majority of cells became GFP-negative. The
response of this population to overnight treatment with PMA
(10 nM), TSA (400 nM), TNFa (10 ng/ml), or a combination of
the three is shown as percentage of cells that became GFP-positive,
in comparison to untreated cells. (B) shRNA-mediated depletion of
Spt6 activates the HIV promoter. HIV latently infected HeLa cells
were infected with Control or Spt6 (#1, target sequence
CGCCTTGTACTGTGAATTTAT)-shRNA expression lentivirus
(pLKO.1-Puro, MISSION, Sigma). Upon puromycin (2 mg/ml)
selection, depletion of this factor was tested in Western blot with
specific antibodies and tubulin as a loading control (upper panel)
and HIV reactivation was followed by FACS analysis of GFP-
positive cells (lower panel). Spt6 depletion and HIV reactivation was
observed at day 9 after infection, but was lost at day 19. (C) HIV
reactivation is achieved with several different shRNAs against Spt6.
As in (B), lentiviruses for the expression of two additional Spt6
shRNAs (#2, CCCTTGAAGAAATCTTGGAAA and #3,
GCCCACCTTCATCCCTTATTT) were integrated into latently
infected HeLa cells at two different multiplicities of infection (here
called low and high, high being 9-fold higher than low). Analysis of
Spt6 depletion by Western blot and of the percentage of HIV-
reactivated cells was performed 9 days after infection. (D) shRNA-
mediated depletion of Chd1 activates the HIV promoter. HIV
latently infected HeLa cells were infected with Control or Chd1
(#1, GCGGTTTATCAAGAGCTATAA; #2, CCACTCT-
TACTTCCTGGCAAA; #3, GCAGTTGTGATGAAACA-
GAAT and #4, CCATCGTGATTGGGATCACTA)-shRNA
expression lentiviruses (pLKO.1-Puro, MISSION, Sigma), at two
different multiplicities of infection. Upon puromycin (2 mg/ml)
selection, the repressive effect of these shRNAs was tested by RT-
quantitative PCR with gene-specific oligonucleotides and GAPDH
as a control (upper panel) and HIV reactivation was followed by
FACS analysis of GFP-positive cells (lower panel). The two shRNAs
with a stronger capability of knocking-down Chd1 promoted clearer
reactivation of latent HIV.
Found at: doi:10.1371/journal.pgen.1000339.s006 (26.14 MB
TIF)
Table S1 Yeast strains.
Found at: doi:10.1371/journal.pgen.1000339.s007 (0.12 MB
DOC)
Table S2 Plasmids used in this work.
Found at: doi:10.1371/journal.pgen.1000339.s008 (0.13 MB
DOC)
Table S3 Primers for real-time PCR.
Found at: doi:10.1371/journal.pgen.1000339.s009 (0.11 MB
DOC)
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